Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Toll-like receptor 7/8/9 antagonists discovered at Bristol-Myers Squibb

Feb. 26, 2019

Bristol-Myers Squibb identifies TLR7/8/9 antagonists

Feb. 22, 2019

EZH2 inhibitors may be a means of treating scleroderma

Feb. 20, 2019

Topline results from Japanese confirmatory phase III study of ONO-5704 in knee osteoarthritis

Feb. 19, 2019

FASST study of lanifibranor in diffuse cutaneous systemic sclerosis does not meet primary endpoint

Feb. 19, 2019

Grant to support phase II development of AKL's APPA for osteoarthritis

Feb. 18, 2019

Nimbus Lakshmi discloses new TYK2 inhibitors

Feb. 14, 2019

Misplaced energy turns T cells proinflammatory

Feb. 7, 2019

Evidence of molecular mechanism of DZ-2002 on glomerulonephritis in SLE

Feb. 5, 2019

TNF levels do not predict TNF blocker success

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...